The study showed no unconventional challenges, which indicated that it may be properly administered in a medical research context. Afterwards, Dr. Charles Grob asked for authorization to even further analyze the compound with most cancers people, but was denied by the FDA twice.copyright was very first synthesized by Merck, a German pharmaceutical